Karen Drexler

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
11 years
Director since
2023

11 years of board service in total across 3 boards, counting each seat separately. Longest: ResMed Inc., 3 years.

ResMed Inc. Director
3 years ยท Since 2023
Valion Bio Inc. Director
3 years ยท Since 2023
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 4, 2026 Outset Medical Inc. Grant or award +10,667 โ€” โ€”
Dec 1, 2025 Outset Medical Inc. Open-market sale โˆ’1,548 $4.37 $6,765
Nov 20, 2025 ResMed Inc. Grant or award +1,073 โ€” โ€”
Jun 2, 2025 Outset Medical Inc. Grant or award +8,983 โ€” โ€”
Mar 10, 2025 Outset Medical Inc. Option exercise +31,250 โ€” โ€”
Nov 20, 2024 ResMed Inc. Grant or award +1,083 โ€” โ€”
May 29, 2024 Outset Medical Inc. Grant or award +25,000 โ€” โ€”
Apr 29, 2024 ResMed Inc. Open-market sale โˆ’425 $214.92 $91,341
Nov 16, 2023 ResMed Inc. Grant or award +884 โ€” โ€”
May 31, 2023 Outset Medical Inc. Grant or award +7,681 โ€” โ€”
Feb 2, 2023 ResMed Inc. Open-market sale โˆ’594 $226.58 $134,589
May 16, 2022 Valion Bio Inc. Other โˆ’15,111 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.